Page last updated: 2024-09-05

sb 203580 and Cell Transformation, Neoplastic

sb 203580 has been researched along with Cell Transformation, Neoplastic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowman, L; Ding, M; Hou, L; Meighan, TG; Shi, X1
Chen, X; Duan, L; He, T; Luo, J; Shi, Q; Tang, M; Wang, H; Weng, Y; Wu, R; Yang, X; Ye, L; Zhang, Y; Zhou, L1
Fabra, A; Guerrero, J; Martínez, J; Quintanilla, M; Santibáñez, JF1
Abbott, RT; Bohling, SD; Buckstein, R; Coupland, RW; Dube, ID; Elenitoba-Johnson, KS; Jenson, SD; Lim, MS; Lin, Z; Palais, RA; Perez-Ordonez, B; Perkins, SL; Shami, PJ; Tripp, S; Wang, LY1
Carpenter, G; Tikhomirov, O1
Shapiro, DJ; Zhang, CC1
Okajima, E; Thorgeirsson, UP1
Eliazer, S; Ilaria, RL; Silvany, RE; Wolff, NC1
Bilter, GK; Der, CJ; Pruitt, K; Pruitt, WM; Westwick, JK1

Other Studies

9 other study(ies) available for sb 203580 and Cell Transformation, Neoplastic

ArticleYear
Induction of miR-21-PDCD4 signaling by tungsten carbide-cobalt nanoparticles in JB6 cells involves ROS-mediated MAPK pathways.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2013, Volume: 32, Issue:1

    Topics: Animals; Apoptosis Regulatory Proteins; Butadienes; Cell Line; Cell Transformation, Neoplastic; Cobalt; Disease Models, Animal; Enzyme Inhibitors; Epidermis; Hydrogen Peroxide; Imidazoles; In Vitro Techniques; MAP Kinase Signaling System; Mice; MicroRNAs; Mitogen-Activated Protein Kinase Kinases; Nanoparticles; Nitriles; Occupational Exposure; Pyridines; Reactive Oxygen Species; RNA-Binding Proteins; Signal Transduction; Tungsten Compounds

2013
S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
    International journal of oncology, 2013, Volume: 42, Issue:3

    Topics: Animals; Calgranulin B; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Hep G2 Cells; Humans; Imidazoles; Liver Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Transplantation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Random Allocation; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays

2013
Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes.
    Biochemical and biophysical research communications, 2002, Aug-16, Volume: 296, Issue:2

    Topics: Animals; Cell Line, Transformed; Cell Transformation, Neoplastic; Curcumin; Dipeptides; Enzyme Inhibitors; Flavonoids; Genes, Reporter; Humans; Imidazoles; Keratinocytes; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Oligodeoxyribonucleotides, Antisense; Promoter Regions, Genetic; Pyridines; ras Proteins; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured

2002
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.
    Proceedings of the National Academy of Sciences of the United States of America, 2003, Jun-10, Volume: 100, Issue:12

    Topics: Apoptosis; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Enzyme Inhibitors; Gene Expression Profiling; Humans; Imidazoles; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Cytokine; Receptors, Growth Factor; Translocation, Genetic; Tumor Cells, Cultured

2003
Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2.
    The Journal of biological chemistry, 2004, Mar-26, Volume: 279, Issue:13

    Topics: Animals; Apoptosis; Blotting, Western; Cell Cycle; Cell Death; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; DNA; DNA Fragmentation; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Fibroblasts; Genetic Vectors; Green Fluorescent Proteins; Humans; Imidazoles; Immunoblotting; Ligands; Luminescent Proteins; Mice; Mitochondria; Mitogen-Activated Protein Kinases; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Protein Structure, Tertiary; Pyridines; Receptor, ErbB-2; Time Factors

2004
Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis.
    The Journal of biological chemistry, 2000, Jan-07, Volume: 275, Issue:1

    Topics: Apoptosis; Breast Neoplasms; Cell Transformation, Neoplastic; Enzyme Induction; Estradiol; Female; HeLa Cells; Humans; Imidazoles; MAP Kinase Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protein-Tyrosine Kinases; Pyridines; Receptors, Estrogen; Recombinant Proteins; Tamoxifen

2000
Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells.
    Biochemical and biophysical research communications, 2000, Apr-02, Volume: 270, Issue:1

    Topics: Animals; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma; Cell Line; Cell Transformation, Neoplastic; Endothelial Growth Factors; Epithelial Cells; Flavonoids; Genes, myc; Genes, ras; Imidazoles; Liver; Lymphokines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Oncogene Proteins v-raf; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Retroviridae Proteins, Oncogenic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
    Oncogene, 2000, Sep-14, Volume: 19, Issue:39

    Topics: 3T3 Cells; Animals; Binding Sites; Bone Neoplasms; Butadienes; Cell Transformation, Neoplastic; Colony-Forming Units Assay; DNA; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Genes, ras; Humans; Imidazoles; MAP Kinase Kinase 1; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mutation; Nitriles; Oncogene Proteins, Fusion; Protein Serine-Threonine Kinases; Proto-Oncogene Protein c-fli-1; Pyridines; RNA-Binding Protein EWS; Sarcoma, Ewing; Transcription Factors; Tumor Cells, Cultured

2000
Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation.
    The Journal of biological chemistry, 2002, Aug-30, Volume: 277, Issue:35

    Topics: Animals; Cell Cycle; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cloning, Molecular; Culture Media, Conditioned; Cyclin D1; Cyclins; Enzyme Inhibitors; Flavonoids; Genes, ras; Imidazoles; Intestinal Mucosa; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Pyridines; Rats; Recombinant Proteins; Transforming Growth Factor alpha

2002